Yew Bio-Pharm Group Inc (YEWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 29,574 | 7,727 | 7,440 | 6,728 | 5,961 |
| Cost of Goods | 22,541 | 2,137 | 2,407 | 1,279 | 1,126 |
| Gross Profit | 7,033 | 5,590 | 5,032 | 5,449 | 4,835 |
| Operating Expenses | 2,434 | 1,441 | 1,542 | 3,523 | 914 |
| Operating Income | 5,140 | 4,286 | 3,898 | 2,205 | 4,047 |
| Other Income | 161 | -2 | 2 | 2 | -6 |
| Pre-tax Income | 5,301 | 4,284 | 3,900 | 2,206 | 4,040 |
| Income Tax | 17 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 5,285 | 4,284 | 3,900 | 2,206 | 4,040 |
| Net Income | $5,285 | $4,284 | $3,900 | $2,206 | $4,040 |
| EPS Basic Total Ops | 0.10 | 0.08 | 0.08 | 0.05 | 0.10 |
| EPS Basic Continuous Ops | 0.10 | 0.08 | 0.08 | 0.05 | 0.10 |
| EPS Diluted Total Ops | 0.10 | 0.07 | 0.08 | 0.05 | 0.08 |
| EPS Diluted Continuous Ops | 0.10 | 0.07 | 0.08 | 0.05 | 0.08 |
| EPS Diluted Before Non-Recurring Items | 0.10 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $12,883 | $4,969 | $4,459 | $2,768 | $4,518 |